Furthermore, retrospective ChEAs of transcription factors in this network implied that PPARα, PPARδ, and RELA likely play important role in differentially control of target gene activity during the reversal of NASH by telmisartan. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.